Benefits
Traditional reputation as a calming herb
Vervain has long been used in folk medicine to calm the nervous system, including for nervous tension, anxiety and poor sleep. That use has not been tested in people: no controlled trial of vervain alone could be found, and the EU, which issued a monograph for lemon verbena for mild stress and sleep, has none for vervain.
Vervain in a five-herb nose and sinus blend compared with placebo
In two pooled placebo-controlled trials in 589 adults with acute viral rhinosinusitis, a dry extract of gentian, primula flower, sorrel, elder flower and vervain (480 mg a day for 15 days) lowered a symptom score about 1.2 points more than placebo by day 14. It was a five-herb product made by the sponsor, so no share of the effect can be given to vervain.
The same five-herb blend over 12 weeks and for sense of smell
In a 929-patient placebo-controlled trial in chronic rhinosinusitis, the five-herb extract did not beat placebo on its main symptom score over 12 weeks; only a post hoc subgroup did better. In another placebo-controlled trial in people with smell loss linked to nasal disease, smell test results showed no major difference between the blend and placebo. Neither tells anything about vervain alone.
Calming and sedative behavior in mice and rats (animal studies)
In mice, a single oral 50 mg/kg dose of a vervain ethanol extract had anxiety-reducing and antidepressant-like effects in maze, light-dark box and tail suspension tests, and extracts made with added valine or arginine acted as sedatives. In rats, 200 mg/kg a day by mouth for 7 days shortened immobility in a swim test. These are animal findings and have not been measured in people.
Mechanism of action
Iridoid glycosides, the herb's marker compounds
Verbenalin and hastatoside are the most characteristic iridoids of vervain, and the European Pharmacopoeia standardizes the herb on a minimum 1.5% verbenalin. The herb also contains verbascoside, the main polyphenol of lemon verbena. How much of these compounds reaches the body from tea or extracts, and what they do in people, has not been studied.
Benzodiazepine-site GABA-A signaling in mice
In mice, an oral vervain ethanol extract delayed and shortened chemically induced seizures, and pretreatment with flumazenil, a drug that blocks the benzodiazepine site of GABA-A receptors, removed that effect. This points to calming GABA signaling as one route of action, but only in animals.
Polyphenols that bind iron in the gut
Herb teas rich in polyphenols reduce absorption of nonheme iron from the same meal, and the effect grew with total polyphenol content. A vervain infusion contained about 771 mg of polyphenols per liter in a lab analysis, and adding vitamin C improved iron availability in a lab digestion model.
Clinical trials
Controlled human absorption study measuring incorporation of radiolabeled iron into red blood cells after a bread meal taken with water or with test beverages, including vervain (Verbena officinalis) tea. (Hurrell et al. 1999, Br J Nutr)
Adult volunteers; each beverage was compared with a water control meal.
Vervain tea reduced nonheme iron absorption from the meal by 59% compared with water. All the polyphenol-containing drinks tested inhibited iron absorption in line with their polyphenol content, from 47% for chamomile to 79 to 94% for black tea. This is a nutrition and safety finding, not a benefit.
Pooled analysis of two randomized, double-blind, placebo-controlled trials (ARhiSi-1 and ARhiSi-2) of BNO 1016, a dry extract of gentian root, primula flower, sorrel herb, elder flower and verbena herb (1:3:3:3:3), 160 mg three times daily by mouth for 15 days. Funded by the maker, Bionorica; one author was its employee and two were its consultants. (Jund et al. 2015, Acta Otolaryngol)
589 patients with acute viral rhinosinusitis (294 BNO 1016, 295 placebo).
The major symptom score fell from about 10.0 to 2.47 on the extract and from 9.87 to 3.63 on placebo, a difference of 1.16 points at day 14 (p < 0.0001), just above the 1-point difference set as clinically relevant; quality of life scores also favored the extract. Responders at day 14 were 93.2% versus 85.1%. No serious adverse events. Vervain is one of five herbs, so its contribution is unknown.
Randomized, placebo-controlled trial (CRS-02) of two dosages of BNO 1016 (Sinupret extract) for 12 weeks; five of the eight authors were from the maker, Bionorica. (Palm et al. 2017, Rhinology)
929 patients with chronic rhinosinusitis.
The extract was not superior to placebo on the primary endpoint, the major symptom score at weeks 8 and 12. Secondary endpoints trended in its favor, and a post hoc subgroup with specialist-diagnosed, longer-lasting and more severe disease did better. Safety and tolerability were good. A five-herb product with a negative main result.
Mouse study of dry vervain extracts (70% ethanol or water, some combined with amino acids) given as a single oral dose of 50 mg/kg by gavage, compared with Sedaphyton, a valerian, motherwort and hawthorn sedative product, in open field, elevated plus maze, black-and-white box and tail suspension tests. Also described a 3D-printing gel for oral dosage forms. (Koshovyi et al. 2025, Plants (Basel))
Mice in nine groups of six.
The 70% ethanol extract showed anxiolytic and antidepressant-like effects; in the tail suspension test, immobility time was 1.22-fold lower than in controls. Extracts made with valine or arginine acted as sedatives, similar to the comparison product. The authors state that effects in people require clinical studies.
OECD guideline 414 prenatal developmental toxicity study of a vervain extract given by mouth once daily from day 6 to day 20 of gestation. (Fateh et al. 2019, Chem Biol Interact)
50 pregnant Sprague-Dawley rats in five groups of 10 (0, 500, 1,000, 2,000 and 3,000 mg/kg).
No mothers died, but weight gain fell, mainly at 2,000 and 3,000 mg/kg. Fetal weight and size fell, pre- and post-implantation loss rose, and incomplete bone formation of the skull, breastbone and foot bones appeared at the two highest doses. The authors conclude vervain use in pregnancy is not safe. Animal data at high doses.